Results 221 to 230 of about 919,409 (398)
Basroparib inhibits YAP‐driven cancers by stabilizing angiomotin
Molecular Oncology, EarlyView.Basroparib, a selective tankyrase inhibitor, suppresses Wnt signaling and attenuates YAP‐driven oncogenic programs by stabilizing angiomotin. It promotes AMOT–YAP complex formation, enforces cytoplasmic YAP sequestration, inhibits YAP/TEAD transcription, and sensitizes YAP‐active cancers, including KRAS‐mutant colorectal cancer, to MEK inhibition.
Young‐Ju Kwon +4 more
wiley +1 more source
<i>Megalomyrmex milenae</i> Transcriptome Reveals a Complex Venom Cocktail. [PDF]
Toxins (Basel)Sozanski KS +4 more
europepmc +1 more source
Cotargeting TREM2 and IL2 pathways triggers multipronged anticancer immunity
Molecular Oncology, EarlyView.Von Locquenghien et al. report that MiTE‐144, a triggering receptor expressed on myeloid cells 2 (TREM2) blocking antibody fused to interleukin‐2 (IL2) variant with tumour microenvironment restricted activation, demonstrates superior anticancer efficiency in a preclinical setting.
Isaure Vanmeerbeek +2 more
wiley +1 more source
Correction: Fernandez et al. Metabarcoding Reveals Diversity of Potentially Toxic Algae in Papeete Port (Tahiti). <i>Toxins</i> 2025, <i>17</i>, 424. [PDF]
Toxins (Basel)Fernandez S +3 more
europepmc +1 more source
Review on uremic toxins: classification, concentration, and interindividual variability.
Kidney International, 2003 R. Vanholder +21 more
semanticscholar +1 more source
Duodenitis-Proximal Jejunitis in Horses After Experimental Administration of Clostridium difficile Toxins [PDF]
, 2016 Luis G. Arroyo +5 more
openalex +1 more source